OTC · Software - Application

Avai Bio, Inc. (AVAI) Stock

$0.17 +9.47% OTC: AVAI Technology

Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences.

Valuation

MetricValue
Price$0.17
Market Cap$23.01M
P/E Ratio-22.49
P/B Ratio-8.22
P/S Ratio0.00
EPS (TTM)$-0.01
52-Week High$0.80
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE70.67%
ROA-305.49%
ROCE52.89%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.56
Current Ratio0.02

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$0$0
Operating Profit$0$0$-2.0M$-2.0M$-1.0M
Net Profit$0$0$-2.0M$-1.0M$-2.0M
EPS$0.00$-0.01$-0.02$-0.01$-0.01
Op Margin-13.7%-126.3%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$1.0M
Total Liabilities$1.0M$1.0M$2.0M$2.0M$3.0M
Cash$0$0$0$0$0
Borrowings$1.0M$1.0M$1.0M$1.0M$2.0M

Latest News

A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up CNW Group · Jul 21, 2026 Avaí Bio and Austrianova Reach Agreement for Insulin-Producing Cells with Internationally Acclaimed Partner to Advance Diabetes Therapy PR Newswire · Jul 21, 2026 Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy PR Newswire · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$-1.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.35
EV / EBITDA-25.79
FCF Yield-4.39%
Quick Ratio0.02
Interest Coverage0.00
Return 1Y-71.60%
Return 3Y-88.76%
Return 5Y-94.63%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSKZFBambuser AB (publ) $1.39 +0.00% -1.28 $11.19M 0.00%
DGGXFDigitalX Limited $0.01 +1.85% -5.62 $20.47M 0.00%
FCGYForecastagility Corporation $0.00 — -0.01 $334611 0.00%
INVUInvestview, Inc. $0.03 -4.81% -3.78 $47.43M 0.00%
MHUBFMinehub Technologies Inc. $0.29 +2.34% -3.00 $29.96M 0.00%

About Avai Bio, Inc.

Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public. The company was established on November 6, 2017, and its main office is situated in Las Vegas, Nevada.

Avai Bio, Inc. is headquartered in US.

Avai Bio, Inc. (AVAI) stock trades at $0.17 with a market capitalization of $23.01M. The stock is valued at a price-to-earnings (P/E) ratio of -22.49, price-to-book of -8.22, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.11 and $0.80, and currently trades 78.8% below its 52-week high.

On profitability, Avai Bio, Inc. generates a return on equity (ROE) of 70.67% — well above the market average, a sign of a high-quality business, return on capital employed of 52.89%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: avaibio.com

Related Technology Stocks

NVDA Semiconductors $223.96 +2.27% AAPL Consumer Electronics $313.33 +0.29% MSFT Software - Infrastructure $499.99 +0.03% AVGO Semiconductors $427.76 +1.71% TSM Semiconductors $374.67 -4.50% MU Semiconductors $739.00 -9.94% AMD Semiconductors $483.36 -1.21% ASML Semiconductors $1550.69 -2.04% INTC Semiconductors $101.65 +1.84% CSCO Communication Equipment $120.59 -0.24% ORCL Software - Infrastructure $146.94 +2.42% AMAT Semiconductors $436.45 -8.40%

Popular Stocks

Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Eli Lilly (LLY)JPMorgan (JPM)Visa (V)Exxon Mobil (XOM)Walmart (WMT)UnitedHealth (UNH)

Screens featuring this stock

High ROE Technology StocksLow P/E Technology StocksHigh Net Margin Technology StocksDividend Technology StocksLow Debt Technology StocksAll stock screens
Run Stock Screener Investing Guides